Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.41 |
| ▸ | MAT2A | P31153 | 1/20 | 0.40 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1094677 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL1094678 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL8356129 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL8359816 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL1094676 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL1109745 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL8360447 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL1109744 | 1.00 | ACMSD (0.47) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL191429 | 0.98 | ACMSD (0.49) | ACMSDELANETDP1PTGS2SIGMAR1 | |
| SCHEMBL8380044 | 0.98 | ACMSD (0.49) | ACMSDELANETDP1PTGS2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4293717-A | Process for preparing aldehydes and diols | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | claimed |
| CN-119264026-A | Method for synthesizing cyclic sulfonamide and sulfonyl olefin by mechanical light excitation | 西北大学 | 2025-01-07 | — | — | CN | disclosed |
| US-9493704-B2 | Cycloheptane derivative and preparation method and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-11-15 | — | — | US | disclosed |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) | 2015-09-10 | — | — | US | disclosed |
| US-8822548-B2 | Compounds with activity at estrogen receptors | ACADIA PHARMACEUTICALS INC. (US) | 2014-09-02 | — | — | US | disclosed |
| EP-2279995-B1 | Process for the production of cycloalkyl alkyl ethers | ZEON CORP (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-8017813-B2 | Process for production of cycloalkyl alkyl ethers | ZEON CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110046237-A1 | COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS | ACADIA PHARMACEUTICALS INC. (US) | 2011-02-24 | — | — | US | disclosed |
| EP-2279995-A2 | Process for producing cycloalkyl alkyl ethers | Zeon Corporation (JP) | 2011-02-02 | — | — | EP | disclosed |
| US-7825265-B2 | di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors; 2-fluoro-1-methoxy-4-(1-phenyl-cyclohexyl)-benzene | ACADIA PHARMACEUTICALS INC. (US) | 2010-11-02 | — | — | US | disclosed |
| WO-2001070675-A2 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE, INC. (CA) | 2001-09-27 | — | — | WO | disclosed |
| US-5932642-A | Cyclic phosphinic acid derivatives as stabilizers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-08-03 | — | — | US | disclosed |
| US-4293717-A | Process for preparing aldehydes and diols | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
| US-4052416-A | FIRE RETARDANTS, FUEL ADDITIVES, AGRICULTURE, PLASTICIZING, CHEMICAL INTERMEDIATES | ALELIO GAETANO F D | 1977-10-04 | — | — | US | disclosed |
| US-4016224-A | FIRE RETARDANTS, FUEL ADDITIVES, PLASTICIZERS | ALELIO GAETANO F D | 1977-04-05 | — | — | US | disclosed |
| US-3985835-A | A PHOSPHORUS-HALOGEN-NITROGEN CONTAINING COMPOUND | ALELIO GAETANO F D | 1976-10-12 | — | — | US | disclosed |
| US-3980737-A | FIRE RETARDANTS, AGRICULTURAL CHEMICALS, FUEL ADDITIVES, PLASTICIZERS, INTERMEDIATES | ALELIO GAETANO F D | 1976-09-14 | — | — | US | disclosed |
| US-3972944-A | BORON OXIDE, BORIC ACID OR BORATE AND VANADIUM OR MOLYBDENUM CONTAINING CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
| US-3970727-A | Halogenated esters of phosphorus-containing acids | ALELIO GAETANO F D | 1976-07-20 | — | — | US | disclosed |
| US-3950457-A | ADDITION POLYMERS OF UNSATURATED CARBOXYLATES | ALELIO GAETANO F D | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046237-A1 | COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS | ESR2, ESR1, GPER1 | ACMSD 4071/4885ELANE 826/4885TDP1 2292/4885 |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | DHPS, DHCR24, CCNT1 | ACMSD 645/4885ELANE 3954/4885TDP1 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.